1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Romania Pharmaceutical Report - Q1, 2015

Romania Pharmaceutical Report - Q1, 2015

  • June 2015
  • -
  • Emerging Markets Direct Media Holdings
  • -
  • 11 pages

This report covers the market developments in Q1/2015 and the data available as of May 2015.



The pharmaceutical sales performed above market expectations and increased at double-digit annual pace in Q1/2014 in RON and EUR terms, after having risen by 11.8% y/y in the previous quarter (up by 9.7% y/y in EUR terms). Sales of OTC drugs surged by 27.7% y/y to RON0.6bn, while the hospital segment amounted to RON0.4bn, up by 11.5% y/y.



In the 12 months ending March 2015, the pharmaceutical market value increased by 10% y/y to RON12.6bn. The Rx segment advanced by 7.4% y/y in RON terms, while the OTC and hospital sales increased by 20.6% y/y and 11.7% y/y respectively.



The performance of the Romanian pharmaceutical market is influenced by a broad variety of factors, among which the most important are related to regulatory measures and public spending. Accordingly, the announced medicine price cuts might drive downwards the pharmaceutical sales value this year, to minus 2.8% y/y in local currency terms, according to market data. In terms of actual demand, however, considering the aging population, there is enough room for growth. Our QuERi database forecasts show that the demand for treatment will continue increasing in 2015-2017.



Key points:

oPharmaceutical sales rise y/y in EUR, RON terms in Q1/2015

oMedicine price cut expected to drive downwards pharma market value in 2015

oPharmaceutical imports, exports decline in 2014

oAntibiotice Iasi seeks investors for building new production capacities

oBiofarm plans acquisition of local peer

oPolisano to sell 25% stake to investment fund for EUR30mn

oDona pharmacy chain launches online store

Table Of Contents

Romania Pharmaceutical Report - Q1, 2015
Contents

Executive summary3

Market overview4

Pharmaceutical sales rise y/y in EUR, RON terms in Q1/20154

Medicine price cut expected to drive downwards pharma market value in 20154

Sanofi tops pharma companies ranking in 12 months ending March 20155

Pharmaceutical imports, exports decline in 20146

Production of medicines inches up 1.5% y/y in Q1/20156

Producers7

Domestic pharmaceutical producers focus on exports, developing OTC portfolio7

Antibiotice Iasi seeks investors for building new production capacities7

Zentiva reports higher revenues, lower profit in Q1/20158

Gedeon Richter's sales in Romania down y/y in Q1/20158

Biofarm plans acquisition of local peer9

Distribution and Retail9

Polisano to sell 25% stake to investment fund for EUR30mn9

Farmaceutica Remedia expects higher revenues, profit this year10

Dona pharmacy chain launches online store10

AandD Pharma moves on with expansion of Punkt chain11

Ropharma plans investments in pharmacy chain expansion this year11



Table 1 Pharmaceutical production in 2011-2015 (monthly, y/y)7

Table 2 Antibiotice SA- Selected financials in 2013-2015 (RON, y/y)8

Table 3 Zentiva SA- Selected financials in 2013-2015 (RON, y/y)8

Table 4 Biofarm SA- Selected financials in 2013-2015 (RON, y/y)9

Table 5 Farmaceutica Remedia SA- Selected financials in 2013-2015 (RON, y/y)10

Table 6 Ropharma S.A.- Selected financials in 2013-2015 (RON, y/y)11



Figure 1 Pharma quarterly sales in 2006-2015 (EURmn, PPP)4

Figure 2 Pharmaceutical market demand in 2007-2017f (annual, $mn)5

Figure 3 Top 10 pharma companies by revenues in 12 months ending March 2015 (RONmn)5

Figure 4 Pharmaceutical products foreign trade in 2003-2014 (monthly, EURmn)6

Figure 5 Pharmaceutical product manufacturing-Foreign trade in 2007-2017f ($mn)6

Figure 6 Pharmaceutical manufacturing index in 2011-2015 (monthly, 2010=100, unadjusted)7


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Dyslipidemia - Global Drug Forecast and Market Analysis to 2025 Summary Sales of dyslipidemia therapeutics is estimated to be approximately $11.2B across the 7MM in 2015, encompassing the ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.